Araştırma Makalesi

The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study

Cilt: 8 Sayı: 3 8 Ekim 2023
PDF İndir
EN TR

The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study

Öz

Objective: The research was methodologically planned and applied to adapt the 6-item self-efficacy scale in chronic disease management of individuals with multiple sclerosis to Turkish society. Material and Method: The research was carried out between January 2021 and March 2021 by using the online questionnaire method with individuals with Multiple Sclerosis registered to the Turkish MS Society. To establish the validity and reliability of the self-efficacy for managing chronic disease six item scale (SEMDC- 6S), the study was carried out with a sample consisting of n=104 individuals, which was more than 10 times the number of items on the scale(six items).For test-retest reliability, the scale was administered to 20 patients twice at a two week interval. Results: The validity of the SEMDC-6S was evaluated with language validity, construct validity, and content validity. The internal consistency coefficient (Cronbach's Alpha) was 0.95, as which was very high.The item-total correlation was examined, and accordingly, no items were excluded from the scale. According to the test-retest results, it was determined that repeated measurements did not differ significantly, and retests had a high correlation. Conclusion: The SEMDC-6S, which was adapted to Turkish society, is a valid and reliable tool. We recommend that it should be applied in different groups and cultures to increase its evidence value.

Anahtar Kelimeler

Destekleyen Kurum

yok

Proje Numarası

FBU/2020-24

Kaynakça

  1. Kasper J, Köpke S, Mühlhauser I, Heesen C. Evidence-Based Patient Information About Treatment of Multiple Sclerosis: A Phase One Study on Comprehension and Emotional Responses. PEC J. 2006; 62:56-63.
  2. Koşar C, Besen D. Kronik Hastalıklarda Hasta Aktifliği: Kavram Analizi. Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi. 2015; 8(1):45-51.
  3. World Health Organization (WHO). Non communicable diseases progress monitor 2020. 2020a. Erişim linki: https://www.who. int/ publications/i/item/ncd-progress-monitor-2020. (Date of Access:10.10.2021).
  4. Schulman-Green D, Jaser S, Martin F, Alonzo A, Grey M, McCorkle R, et al. Processes of self-management in chronic illness. J Nurs Scholarsh. 2012; 44(2):136-144.
  5. Barlow J, Sturt J, Hearns Haw H. Self-management interventions for people with chronic conditions in primary care: Examples from arthritis, asthma and diabetes. Health Education Journal. 2002a; 61:365-378.
  6. Dufour SP, Graham S, Friesen J, Rosenblat M, Rous C, Richardson J. Physiotherapists supporting self-management through health coaching: a mixed methods program evaluation. Physiother Theory Pract. 2014; 1:1-10.
  7. Fortin M, Haggerty J, Almirall J, Bouhali T, Sasseville M, Lemieux M. Life style factor sand multimorbidity: a cross sectionalstudy. BMC Public Health. 2014; 14:686.
  8. Dorstyn D, Black R, Mpofu E, Kneebone I. Utilizingthe ICF to understand depressive symptomology in multiple sclerosis: An exploratory systematic review. Rehabil Psychol. 2017; 62(2):143-64.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Erken Görünüm Tarihi

8 Ekim 2023

Yayımlanma Tarihi

8 Ekim 2023

Gönderilme Tarihi

1 Şubat 2023

Kabul Tarihi

28 Mayıs 2023

Yayımlandığı Sayı

Yıl 2023 Cilt: 8 Sayı: 3

Kaynak Göster

APA
Eroğlu, N., & Temiz, G. (2023). The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 8(3), 963-968. https://doi.org/10.61399/ikcusbfd.1245472
AMA
1.Eroğlu N, Temiz G. The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study. İKÇÜSBFD. 2023;8(3):963-968. doi:10.61399/ikcusbfd.1245472
Chicago
Eroğlu, Nermin, ve Gamze Temiz. 2023. “The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study”. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 8 (3): 963-68. https://doi.org/10.61399/ikcusbfd.1245472.
EndNote
Eroğlu N, Temiz G (01 Ekim 2023) The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 8 3 963–968.
IEEE
[1]N. Eroğlu ve G. Temiz, “The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study”, İKÇÜSBFD, c. 8, sy 3, ss. 963–968, Eki. 2023, doi: 10.61399/ikcusbfd.1245472.
ISNAD
Eroğlu, Nermin - Temiz, Gamze. “The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study”. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 8/3 (01 Ekim 2023): 963-968. https://doi.org/10.61399/ikcusbfd.1245472.
JAMA
1.Eroğlu N, Temiz G. The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study. İKÇÜSBFD. 2023;8:963–968.
MLA
Eroğlu, Nermin, ve Gamze Temiz. “The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study”. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, c. 8, sy 3, Ekim 2023, ss. 963-8, doi:10.61399/ikcusbfd.1245472.
Vancouver
1.Nermin Eroğlu, Gamze Temiz. The 6-item Self-Efficacy Scale in the Management of Chronic Disease in Individuals with Multiple Sclerosis (MS-CHOYO): Validity and Reliability Study. İKÇÜSBFD. 01 Ekim 2023;8(3):963-8. doi:10.61399/ikcusbfd.1245472

Cited By